Arbekacin Sulfate
硫酸阿贝卡星
Report date: 2023/01/30 17:45:06
NMEQIDP
Base Information
Drug NameArbekacin Sulfate
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1990/09/28
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaDiscontinued
Originator CompaniesMeiji Seika PharmaMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMeiji Seika Pharmatech Co Ltd
Inactive CompaniesKobe UniversityReyon Pharmaceutical Co Ltd
Active Indications
Inactive Indications